TAK-330

· Takeda Pharmaceutical Company Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAK-330, covering 2026-01-28 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery [Phase 3]